摘要
目的 :对比用碘-131与抗甲状腺药治疗甲状腺功能亢进症(甲亢)的临床效果。方法 :将2016年2月至2018年1月期间武胜县人民医院收治的76例甲亢患者作为研究对象。将这76例患者平均分为对照组和观察组。为对照组患者使用抗甲状腺药进行治疗,为观察组患者使用^(131)I进行治疗。然后,比较两组患者的治疗效果、不良反应的发生率及其病情的复发率。结果 :经过治疗,与对照组患者相比,观察组患者治疗的总有效率更高,其不良反应的发生率和病情的复发率均更低,P <0.05。结论 :与使用抗甲状腺药相比,用^(131)I治疗甲亢的效果更好,可明显降低其不良反应的发生率和病情的复发率。
Objective： To compare the clinical effects of 131I and antithyroidism in the treatment of hyperthyroidism. Methods： 76 cases of hyperthyroidism admitted to wusheng people＇s hospital from February 2016 to January 2018 were studied. The 76 patients were divided into a control group and an observation group on average. Antithyroid drugs were used in the control group and 131I was used in the observation group. Then, the treatment effect, the incidence of adverse reactions and the recurrence rate were compared between the two groups. Results： after treatment, compared with the control group, the total therapeutic efficiency of the observation group was higher, and the incidence of adverse reactions and the recurrence rate of the disease were both lower, P 0.05. Conclusion： compared with the use of anti-thyroid drugs, ^（131）I is more effective in the treatment of hyperthyroidism, which can significantly reduce the incidence of adverse reactions and the recurrence rate of the disease.
作者
郑杨
Zheng Yang(wusheng people＇s hospital,Guang＇an Sichuan 63840)
